Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36884323

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 Mar 9
First author
Gounder M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 May;20(5):284. doi: 10.1038/s41571-023-00758-x.
    note
    Source null
    related pmid
    36997640
    relationship
    Comment in
  2. citation
    Future Oncol. 2025 Apr;21(8):889-901. doi: 10.1080/14796694.2025.2462519.
    note
    Source null
    related pmid
    40070345
    relationship
    Update in

Authors and identifiers

  1. name
    Gounder M
    type
    Author
  2. name
    Ratan R
    type
    Author
  3. name
    Alcindor T
    type
    Author
  4. name
    Schöffski P
    type
    Author
  5. name
    van der Graaf WT
    type
    Author
  6. name
    Wilky BA
    type
    Author
  7. name
    Riedel RF
    type
    Author
  8. name
    Lim A
    type
    Author
  9. name
    Smith LM
    type
    Author
  10. name
    Moody S
    type
    Author
  11. name
    Attia S
    type
    Author
  12. name
    Chawla S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gounder M
    type
    Author
  2. name
    Ratan R
    type
    Author
  3. name
    Alcindor T
    type
    Author
  4. name
    Schöffski P
    type
    Author
  5. name
    van der Graaf WT
    type
    Author
  6. name
    Wilky BA
    type
    Author
  7. name
    Riedel RF
    type
    Author
  8. name
    Lim A
    type
    Author
  9. name
    Smith LM
    type
    Author
  10. name
    Moody S
    type
    Author
  11. name
    Attia S
    type
    Author
  12. name
    Chawla S
    type
    Author
bibliography ids
  1. nci-bib-e4ed34a1cbce5eff948894fa
book metadata
content sha256
f46d8818f6ccff137ab3dc556de6f79b757c82ab63c4265a077001063dd23474
document type
citation
dois
  1. 10.1056/NEJMoa2210140
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:36884323
immutable id
pubmed:36884323@f46d8818f6ccff137ab3dc556de6f79b757c82ab63c4265a077001063dd23474
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
10
name
The New England journal of medicine
nlm unique id
0255562
pages
898-912
volume
388
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 May;20(5):284. doi: 10.1038/s41571-023-00758-x.
    note
    Source null
    related pmid
    36997640
    relationship
    Comment in
  2. citation
    Future Oncol. 2025 Apr;21(8):889-901. doi: 10.1080/14796694.2025.2462519.
    note
    Source null
    related pmid
    40070345
    relationship
    Update in
outcomes validated
false
pmid
36884323
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
13ee16546f4679d90a93c168b2a3cc995ef72bd867b54a73e333163bf8ed46ce
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Mar 9
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36884323/
title
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.

Preserved source evidence · Not medical advice